Akero Therapeutics
AKRO
AKRO
253 hedge funds and large institutions have $4.92B invested in Akero Therapeutics in 2025 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 87 increasing their positions, 87 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
253
Holders Change
+14
Holders Change %
+5.86%
% of All Funds
3.39%
Holding in Top 10
16
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+23.08%
% of All Funds
0.21%
New
55
Increased
87
Reduced
87
Closed
39
Calls
$100M
Puts
$48.2M
Net Calls
+$51.8M
Net Calls Change
+$37.2M
Top Buyers
1 |
ACA
Avoro Capital Advisors
New York
|
+$187M |
2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$118M |
3 |
WP
Woodline Partners
San Francisco,
California
|
+$106M |
4 |
Holocene Advisors
New York
|
+$57.4M |
5 |
Bank of America
Charlotte,
North Carolina
|
+$56.6M |
Top Sellers
1 |
Wellington Management Group
Boston,
Massachusetts
|
-$135M |
2 |
RI
RTW Investments
New York
|
-$104M |
3 |
SG Americas Securities
New York
|
-$61.3M |
4 |
Citadel Advisors
Miami,
Florida
|
-$39.5M |
5 |
BlackRock
New York
|
-$25.4M |